[144] HOME DEPOT, INC. SEC Filing
Form 144 filed regarding the proposed sale of Home Depot, Inc. (HD) common stock. The filer notifies a broker (Merrill Lynch, Atlanta) of an intended sale of 2,303 common shares with an aggregate market value of $974,433.85, to be sold on 09/12/2025 on the NYSE. The filing states these shares were acquired the same day, 09/12/2025, through the exercise of a stock award from The Home Depot, Inc., and the payment is described as compensatory. The filing also lists a prior sale by the same person, William D. Bastek, of 3,783 shares on 08/22/2025 for gross proceeds of $1,551,909.30. The notice includes the standard representation that the seller lacks undisclosed material adverse information about the issuer.
- Key transaction details disclosed: class, quantity, broker, aggregate value, acquisition method, and sale date are all provided
- Prior recent sale disclosed: transparency about a 08/22/2025 sale of 3,783 shares for $1,551,909.30
- No indication of a 10b5-1 plan or plan adoption date is provided in the filing text
- Limited context on materiality: the filing does not state the filer’s total holdings or percentage ownership to assess impact
Insights
TL;DR: Insiders are liquidating a modest number of shares from exercised awards; not clearly material to Home Depot's fundamentals.
The filing documents a proposed sale of 2,303 shares acquired via exercise of a stock award and designated as compensatory payment, to be executed through Merrill Lynch on the NYSE. A recent prior disposition of 3,783 shares for about $1.55 million is disclosed. These transactions appear to be routine insider liquidity following award exercise rather than operational developments. The filing does not disclose any undisclosed adverse information and contains standard representations under Rule 144.
TL;DR: Form 144 appears complete for a Rule 144 sale; no compliance red flags in the disclosed fields.
The notice identifies the broker, class, quantity, aggregate value, acquisition method (stock award exercise), and sale dates, fulfilling core Rule 144 disclosure elements. The signature/representation language is present. The filing does not indicate reliance on a trading plan or Rule 10b5-1; no material omissions are apparent in the provided text. Additional context (e.g., plan adoption date) is not included in this content.